Carregando...
The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathy
BACKGROUND: After 5 years since the registration of rifaximin-α as a secondary prophylaxis for overt hepatic encephalopathy (HE) in the Netherlands, we aimed to evaluate the use of hospital resources and safety of rifaximin-α treatment in a real-world setting. METHODS: We carried out prospective id...
Na minha lista:
| Publicado no: | Therap Adv Gastroenterol |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6591657/ https://ncbi.nlm.nih.gov/pubmed/31258622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819858256 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|